Home » FDA, European Commission Outline Challenges to Personalized Medicine
FDA, European Commission Outline Challenges to Personalized Medicine
November 7, 2013
The FDA and the European Commission issued back-to-back reports outlining efforts to regulate drug and device development in the context of personalized medicine. Both regulators see potential in the approach to boost innovation and patient safety.